Karen Kam1, Athena McConnell2. 1. Section of Respiratory Medicine, Alberta Children's Hospital, Calgary, Alberta; 2. Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan.
Abstract
BACKGROUND: It is recommended that household contacts of children with cystic fibrosis and household contacts of children <2 years of age receive annual influenza vaccinations. There is little information documenting whether this recommendation is being followed. METHODS: A 20-question survey was distributed to caregivers of children with cystic fibrosis and to caregivers of healthy children <17 years of age seen in a Saskatoon (Saskatchewan) tertiary care centre. Survey questions addressed the influenza vaccination status of the child and household contacts. Respondents were also asked to rate the influence of various factors on the decision to vaccinate, using a 5-point Likert scale. RESULTS: Reported vaccination rates were 21%, 25% and 7% among household contacts of children with cystic fibrosis, children <2 years of age and children ≥2 years of age, respectively. Advice from their physician, belief that they were too healthy, and inconvenient times and locations of vaccination centres were significant influences when compared among the three groups. Other main deterrents to vaccination were belief that the vaccine does not prevent influenza and belief that its side effects are greater than its benefits. CONCLUSION: By understanding motivators and barriers to vaccination among household contacts of children with cystic fibrosis, effective strategies may be implemented to improve vaccination coverage against influenza. Strong recommendations by clinicians and improved access to vaccination centres are essential components in improving influenza vaccination coverage.
BACKGROUND: It is recommended that household contacts of children with cystic fibrosis and household contacts of children <2 years of age receive annual influenza vaccinations. There is little information documenting whether this recommendation is being followed. METHODS: A 20-question survey was distributed to caregivers of children with cystic fibrosis and to caregivers of healthy children <17 years of age seen in a Saskatoon (Saskatchewan) tertiary care centre. Survey questions addressed the influenza vaccination status of the child and household contacts. Respondents were also asked to rate the influence of various factors on the decision to vaccinate, using a 5-point Likert scale. RESULTS: Reported vaccination rates were 21%, 25% and 7% among household contacts of children with cystic fibrosis, children <2 years of age and children ≥2 years of age, respectively. Advice from their physician, belief that they were too healthy, and inconvenient times and locations of vaccination centres were significant influences when compared among the three groups. Other main deterrents to vaccination were belief that the vaccine does not prevent influenza and belief that its side effects are greater than its benefits. CONCLUSION: By understanding motivators and barriers to vaccination among household contacts of children with cystic fibrosis, effective strategies may be implemented to improve vaccination coverage against influenza. Strong recommendations by clinicians and improved access to vaccination centres are essential components in improving influenza vaccination coverage.
Authors: Harish Nair; W Abdullah Brooks; Mark Katz; Anna Roca; James A Berkley; Shabir A Madhi; James Mark Simmerman; Aubree Gordon; Masatoki Sato; Stephen Howie; Anand Krishnan; Maurice Ope; Kim A Lindblade; Phyllis Carosone-Link; Marilla Lucero; Walter Ochieng; Laurie Kamimoto; Erica Dueger; Niranjan Bhat; Sirenda Vong; Evropi Theodoratou; Malinee Chittaganpitch; Osaretin Chimah; Angel Balmaseda; Philippe Buchy; Eva Harris; Valerie Evans; Masahiko Katayose; Bharti Gaur; Cristina O'Callaghan-Gordo; Doli Goswami; Wences Arvelo; Marietjie Venter; Thomas Briese; Rafal Tokarz; Marc-Alain Widdowson; Anthony W Mounts; Robert F Breiman; Daniel R Feikin; Keith P Klugman; Sonja J Olsen; Bradford D Gessner; Peter F Wright; Igor Rudan; Shobha Broor; Eric A F Simões; Harry Campbell Journal: Lancet Date: 2011-11-10 Impact factor: 79.321
Authors: Angélica M M de Vrankrijker; Tom F W Wolfs; Oana Ciofu; Niels Høiby; Cornelis K van der Ent; Steen S Poulsen; Helle Krogh Johansen Journal: J Med Virol Date: 2009-12 Impact factor: 2.327
Authors: Doren D Fredrickson; Terry C Davis; Connie L Arnould; Estela M Kennen; Sharon G Hurniston; J Thomas Cross; Joseph A Bocchini Journal: Fam Med Date: 2004-06 Impact factor: 1.756
Authors: Dennis Wat; Colin Gelder; Sam Hibbitts; Ian Bowler; Marcus Pierrepoint; Rachel Evans; Iolo Doull Journal: J Cyst Fibros Date: 2007-07-05 Impact factor: 5.482
Authors: Bart E Van Ewijk; Tom F W Wolfs; Piet C Aerts; Kok P M Van Kessel; Andre Fleer; Jan L L Kimpen; Cornelis K Van der Ent Journal: Pediatr Res Date: 2007-04 Impact factor: 3.756
Authors: Tabatha N Offutt-Powell; Rohit P Ojha; Tara M Brinkman; Joseph E Tota; Bradford E Jackson; Karan P Singh; Jennifer S Smith Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452